Lamdong Pharmaceutical JSC (HNX:LDP)
7,800.00
-100.00 (-1.27%)
At close: May 15, 2026
HNX:LDP Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19,371 | 18,614 | 11,451 | 16,205 | 16,619 | 65,159 |
Short-Term Investments | 190.04 | 2,215 | 3,014 | 2,896 | 1,788 | - |
Trading Asset Securities | 10,000 | - | 2,692 | 1,121 | - | - |
Cash & Short-Term Investments | 29,561 | 20,829 | 17,157 | 20,222 | 18,407 | 65,159 |
Cash Growth | 42.67% | 21.40% | -15.15% | 9.86% | -71.75% | 130.59% |
Accounts Receivable | 36,681 | 44,699 | 27,466 | 21,535 | 21,415 | 23,286 |
Other Receivables | 2,412 | 750.84 | 1,207 | 1,238 | 10,819 | 432.72 |
Receivables | 39,093 | 53,450 | 36,673 | 30,773 | 32,234 | 23,719 |
Inventory | 57,559 | 55,422 | 48,962 | 37,751 | 55,919 | 54,575 |
Prepaid Expenses | 1,594 | 1,864 | 2,076 | 220.82 | 957.04 | 284.73 |
Other Current Assets | 122,029 | 118,935 | 51,865 | 51,026 | 51,458 | 545.85 |
Total Current Assets | 249,836 | 250,500 | 156,733 | 139,993 | 158,976 | 144,283 |
Property, Plant & Equipment | 38,458 | 38,655 | 42,555 | 46,329 | 55,742 | 60,718 |
Other Intangible Assets | - | - | 68.6 | 229.47 | 491.92 | 740.21 |
Long-Term Accounts Receivable | 9,300 | 9,300 | - | - | - | - |
Other Long-Term Assets | 9,118 | 9,306 | 7,800 | 8,221 | 13,164 | 10,180 |
Total Assets | 306,713 | 307,760 | 207,157 | 194,773 | 228,374 | 215,921 |
Accounts Payable | 26,625 | 30,970 | 31,545 | 23,549 | 31,801 | 13,964 |
Accrued Expenses | 18,737 | 22,058 | 16,705 | 8,887 | 7,216 | 3,345 |
Short-Term Debt | 61,075 | 56,974 | 55,026 | 65,368 | 70,298 | 29,960 |
Current Portion of Long-Term Debt | - | - | - | 591.64 | - | - |
Current Income Taxes Payable | - | - | - | 157.19 | 1,063 | 7,209 |
Current Unearned Revenue | 501.6 | 134.18 | 134.18 | - | 60 | 72 |
Other Current Liabilities | 5,564 | 4,349 | 2,692 | 2,134 | 3,138 | 3,933 |
Total Current Liabilities | 112,502 | 114,485 | 106,103 | 100,687 | 113,574 | 58,483 |
Long-Term Debt | - | - | - | - | 591.64 | 2,339 |
Other Long-Term Liabilities | 1,780 | 1,780 | 1,770 | 1,720 | 1,720 | 1,720 |
Total Liabilities | 114,282 | 116,265 | 107,873 | 102,407 | 115,886 | 62,541 |
Common Stock | 187,282 | 187,282 | 127,032 | 127,032 | 127,032 | 127,032 |
Additional Paid-In Capital | 4,203 | 4,203 | - | - | - | - |
Retained Earnings | 946.35 | 10.89 | -27,747 | -34,666 | -14,543 | 26,348 |
Treasury Stock | -0.32 | -0.32 | -0.32 | -0.32 | -0.32 | -0.32 |
Shareholders' Equity | 192,431 | 191,496 | 99,284 | 92,366 | 112,489 | 153,380 |
Total Liabilities & Equity | 306,713 | 307,760 | 207,157 | 194,773 | 228,374 | 215,921 |
Total Debt | 61,075 | 56,974 | 55,026 | 65,960 | 70,889 | 32,299 |
Net Cash (Debt) | -31,513 | -36,145 | -37,869 | -45,738 | -52,482 | 32,860 |
Net Cash Per Share | -2023.15 | -2569.07 | -2981.06 | -3600.54 | -4132.07 | 2586.61 |
Filing Date Shares Outstanding | 18.73 | 18.73 | 12.7 | 12.7 | 12.7 | 12.7 |
Total Common Shares Outstanding | 18.73 | 18.73 | 12.7 | 12.7 | 12.7 | 12.7 |
Working Capital | 137,334 | 136,015 | 50,630 | 39,305 | 45,402 | 85,800 |
Book Value Per Share | 10274.97 | 10225.02 | 7815.75 | 7271.08 | 8855.18 | 12073.06 |
Tangible Book Value | 192,431 | 191,496 | 99,216 | 92,136 | 111,997 | 152,640 |
Tangible Book Value Per Share | 10274.97 | 10225.02 | 7810.35 | 7253.02 | 8816.45 | 12014.79 |
Buildings | 62,465 | 62,465 | 62,604 | 62,903 | - | - |
Machinery | 38,114 | 37,950 | 61,717 | 62,170 | - | - |
Construction In Progress | 3,685 | 2,995 | 2,851 | - | 690.2 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.